Applied Statistics

Surgery: Emory University

Total Score People Score Events Score
15 15 13
Date Event Presentation Speakers
February 13, 2016 16th Annual International Symposium On congenital heart disease ADMINISTRATORS PATHWAY | Finding Time and Resources for Advocacy within a Heart Institute with a Busy Clinical Service Robert Campbell
February 18, 2015 8th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2015) SESSION 13 – PLENARY – YEARBOOK Chairmen: Moshe Phillip and Tadej Battelino Bruce Bode
SESSION 1 – PLENARY TECHNOLOGIES AND TYPE 2 DIABETES Bruce Bode
February 23, 2013 Cardiovascular Research Technologies (CRT) 2013 Valve & Structural Heart Revolution I | MitraClip Results in Low and High Risk Degenerative MR: Emerging Data and Integrated Recommendations Peter C. Block
Valve & Structural Heart Revolution I | Percutaneous Mitral Valve Complications and Bailout Peter C. Block
Valve & Structural Heart Revolution I | MORE MITRAL VALVE INTERVENTIONS Peter C. Block
Valve & Structural Heart Revolution I | Panel Discussion: Is Percutaneous Valve Repair Ready for Prime Time? For Whom? Peter C. Block
Valve & Structural Heart Revolution I | Panel Discussion: What Should Be the Optimal Approach for Mitral Valve Repair - Minimally Invasive or Median Sternotomy Percutaneous Approach? Peter C. Block
Valve & Structural Heart Revolution I | Clinical Experience with Percutaneous Mitral Repair Peter C. Block
November 18, 2011 16th Annual Perspectives In Thoracic Oncology MET kinase inhibitors as therapeutic agents Suresh Ramalingam
Angiogenesis inhibition | Bevacizumab and beyond Suresh Ramalingam
October 10, 2011 15th Annual Meeting Collaborative Group of the Americas, on Inherited Colorectal Cancer (CGA-ICC) Public Health Genomics and Lynch Syndrome Universal Screening Cecelia A. Bellcross
Ethical Issues in Hereditary Colorectal Cancer Rebecca Pentz
August 3, 2011 21st Annual Mayo Clinic Hematology/Oncology Reviews An Update on HER2 Positive Breast Cancer Brian Leyland Jones
April 29, 2011 8th CURRENT TRENDS IN AORTIC AND CARDIOTHORACIC SURGERY Is There Still a Raging Debate Over Off-Pump vs. On-Pump CABG Surgery? John D. Puskas
April 15, 2010 UCSF Vascular Symposium 2010 Beyond PTFE and Dacron: New Alternatives for Bypass Grafts Elliot Chaikof
COMPLEX AORTIC DISEASES Elliot Chaikof
Repair of Small AAA: Current Guidelines Elliot Chaikof
January 29, 2010 Advances in Nuclear Cardiology & Cardiac CT: 24th Annual Case Review with the Experts What Lessons Have We Learned from Myocardial Perfusion Imaging in Randomized Trials LESLEE J. SHAW
Prognostication with CT Coronary Calcium Scoring: How Does It Fit into a Preventive Algorithm LESLEE J. SHAW
November 6, 2009 Clinical Applications for Age Management Medicine An Integrative Approach to Women's Health and Bio-Identical Hormone Therapy Anna Cabeca
February 28, 2009 AMERICAN SHOULDER AND ELBOW SURGEONS Normalization of Glenohumeral Articular Contact Pressures after Either Latarjet or Iliac Crest Bone Grafting Procedure: Impact of Graft Type, Position, and Coracoid Orientation Jordan Goldstein
May 30, 2008 ASCO Annual'08 Meeting ethics-- Erythropoiesis-Stimulating Agents Use and Overuse: How Do Oncologists Negotiate Conflicting Demands? Fadlo Raja Khuri
genitourinary cancer-- Prostate Cancer in Black Americans: Is It a Different Disease? Otis W. Brawley
health services research-- Prostate Cancer in Black Americans: Is It a Different Disease? Otis W. Brawley
health services research-- Erythropoiesis-Stimulating Agents Use and Overuse: How Do Oncologists Negotiate Conflicting Demands? Fadlo Raja Khuri
international-- Erythropoiesis-Stimulating Agents Use and Overuse: How Do Oncologists Negotiate Conflicting Demands? Fadlo Raja Khuri
September 26, 2007 Cardiometabolic Health Congress 2007 Risk Assessment Models to Predict Multiple Cardiometabolic Risk Factors Peter WF Wilson
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.